Free Trial

Jane Street Group LLC Sells 34,705 Shares of Amdocs Limited (NASDAQ:DOX)

Amdocs logo with Computer and Technology background

Jane Street Group LLC cut its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 65.2% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,523 shares of the technology company's stock after selling 34,705 shares during the period. Jane Street Group LLC's holdings in Amdocs were worth $1,620,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Janus Henderson Group PLC raised its position in shares of Amdocs by 1.7% in the third quarter. Janus Henderson Group PLC now owns 6,625,875 shares of the technology company's stock valued at $579,632,000 after purchasing an additional 111,357 shares during the period. Pzena Investment Management LLC raised its holdings in Amdocs by 12.3% in the 3rd quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company's stock worth $556,700,000 after acquiring an additional 696,136 shares during the period. LSV Asset Management lifted its position in Amdocs by 7.9% during the 2nd quarter. LSV Asset Management now owns 3,207,155 shares of the technology company's stock worth $253,109,000 after acquiring an additional 234,096 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in Amdocs by 36.6% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company's stock worth $277,818,000 after acquiring an additional 851,022 shares during the last quarter. Finally, Brandes Investment Partners LP boosted its holdings in Amdocs by 31.1% during the second quarter. Brandes Investment Partners LP now owns 2,260,811 shares of the technology company's stock valued at $178,335,000 after acquiring an additional 536,359 shares during the period. Institutional investors and hedge funds own 92.02% of the company's stock.

Amdocs Stock Performance

DOX traded down $0.91 during trading on Friday, reaching $85.79. 621,450 shares of the company's stock were exchanged, compared to its average volume of 682,727. Amdocs Limited has a fifty-two week low of $74.41 and a fifty-two week high of $94.04. The company has a quick ratio of 1.24, a current ratio of 1.20 and a debt-to-equity ratio of 0.21. The business has a 50 day moving average price of $87.70 and a 200 day moving average price of $85.03. The company has a market capitalization of $9.68 billion, a P/E ratio of 20.23, a PEG ratio of 1.45 and a beta of 0.72.

Amdocs Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.479 per share. The ex-dividend date is Tuesday, December 31st. This represents a $1.92 annualized dividend and a dividend yield of 2.23%. Amdocs's dividend payout ratio (DPR) is currently 45.05%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on DOX. Oppenheimer lifted their price target on Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a research report on Wednesday, November 13th. Stifel Nicolaus assumed coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They set a "buy" rating and a $100.00 target price on the stock. StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Thursday, November 14th. Finally, Barclays reduced their price target on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $101.20.

View Our Latest Stock Report on Amdocs

Amdocs Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Recommended Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Small Caps, Financials & Bitcoin Lead the Rising Bull Market: Chris Rowe’s Top Picks
Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines